Re­gor’s obe­si­ty pill posts mut­ed weight loss in Phase 2a, en­ters new tri­al

The weight loss with Re­gor Ther­a­peu­tics’ obe­si­ty pill does not look quite as strong as com­pet­ing prod­ucts — and the biotech’s in­ter­est in find­ing a part­ner …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.